Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses.
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses.
复制标题
自动虚拟现实认知疗法与虚拟现实精神放松疗法治疗精神病患者持续性被害妄想(THRIVE):在英国进行的一项平行组、单盲、随机对照试验,并进行中介分析。
DOI:
10.1016/s2215-0366(23)00257-2
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Freeman D
中科院分区:
文献类型:
--
作者:
Freeman D
BackgroundPersecutory delusions are a major psychiatric problem that often do not respond sufficiently to standard pharmacological or psychological treatments. We developed a new brief automated virtual reality (VR) cognitive treatment that has the potential to be used easily in clinical services. We aimed to compare VR cognitive therapy with an alternative VR therapy (mental relaxation), with an emphasis on understanding potential mechanisms of action.MethodsTHRIVE was a parallel-group, single-blind, randomised controlled trial across four UK National Health Service trusts in England. Participants were included if they were aged 16 years or older, had a persistent (at least 3 months) persecutory delusion held with at least 50% conviction, reported feeling threatened when outside with other people, and had a primary diagnosis from the referring clinical team of a non-affective psychotic disorder. We randomly assigned (1:1) patients to either THRIVE VR cognitive therapy or VR mental relaxation, using a permuted blocks algorithm with randomly varying block size, stratified by severity of delusion. Usual care continued for all participants. Each VR therapy was provided in four sessions over approximately 4 weeks, supported by an assistant psychologist or clinical psychologist. Trial assessors were masked to group allocation. Outcomes were assessed at 0, 2 (therapy mid-point), 4 (primary endpoint, end of treatment), 8, 16, and 24 weeks. The primary outcome was persecutory delusion conviction, assessed by the Psychotic Symptoms Rating Scale (PSYRATS; rated 0–100%). Outcome analyses were done in the intention-to-treat population. We assessed the treatment credibility and expectancy of the interventions and the two mechanisms (defence behaviours and safety beliefs) that the cognitive intervention was designed to target. This trial is prospectively registered with the ISRCTN registry, ISRCTN12497310.FindingsFrom Sept 21, 2018, to May 13, 2021 (with a pause due to COVID-19 pandemic restrictions from March 16, 2020, to Sept 14, 2020), we recruited 80 participants with persistent persecutory delusions (49 [61%] men, 31 [39%] women, with a mean age of 40 years [SD 13, range 18–73], 64 [80%] White, six [8%] Black, one [1%] Indian, three [4%] Pakistani, and six [8%] other race or ethnicity). We randomly assigned 39 (49%) participants assigned to VR cognitive therapy and 41 (51%) participants to VR mental relaxation. 33 (85%) participants who were assigned to VR cognitive therapy attended all four sessions, and 35 (85%) participants assigned to VR mental relaxation attended all four sessions. We found no significant differences between the two VR interventions in participant ratings of treatment credibility (adjusted mean difference –1·55 [95% CI –3·68 to 0·58]; p=0·15) and outcome expectancy (–0·91 [–3·42 to 1·61]; p=0·47). 77 (96%) participants provided follow-up data at the primary timepoint. Compared with VR mental relaxation, VR cognitive therapy did not lead to a greater improvement in persecutory delusions (adjusted mean difference –2·16 [–12·77 to 8·44]; p=0·69). Compared with VR mental relaxation, VR cognitive therapy did not lead to a greater reduction in use of defence behaviours (adjusted mean difference –0·71 [–4·21 to 2·79]; p=0·69) or a greater increase in belief in safety (–5·89 [–16·83 to 5·05]; p=0·29). There were 17 serious adverse events unrelated to the trial (ten events in seven participants in the VR cognitive therapy group and seven events in five participants in the VR mental relaxation group).InterpretationThe two VR interventions performed similarly, despite the fact that they had been designed to affect …
登录
查看更多内容
影响因子:
4.5
作者:
Freeman, Daniel;Taylor, Kathryn M.;Waite, Felicity
通讯作者:
Waite, Felicity
DOI:
10.1192/bjp.bp.115.176438
发表时间:
2016-07
期刊:
The British journal of psychiatry : the journal of mental science
影响因子:
--
作者:
Freeman D;Bradley J;Antley A;Bourke E;DeWeever N;Evans N;Černis E;Sheaves B;Waite F;Dunn G;Slater M;Clark DM
通讯作者:
Clark DM
影响因子:
11.3
作者:
Ophélie Rault;H. Lamothe;A. Pelissolo
通讯作者:
A. Pelissolo
影响因子:
5.9
作者:
Clark, David M.;Ehlers, Anke;Wild, Jennifer
通讯作者:
Wild, Jennifer
DOI:
10.1016/s0005-7916(00)00012-4
发表时间:
2000-06-01
影响因子:
1.8
作者:
Devilly, GJ;Borkovec, TD
通讯作者:
Borkovec, TD